Global Top 10 Medtechs Swap Places After Latest Quarterlies
Market pressures, changing COVID-related demand, restructuring and currency movements evident in the top medtechs’ latest financials
Abbott Laboratories moved above Medtronic in MAT medtech revenues, while Philips Healthcare and Stryker finished 2022 with strong quarters, and Roche dropped a few places.
You may also be interested in...
Medtronic announced plans to spin off its patient monitoring and respiratory interventions businesses, which currently provide revenues of over $2bn a year. The company previously signaled plans to make significant changes to its business portfolio.
The trend among device innovators to focus on diagnostic technologies that improve imaging, offer better visualization of tissues and avoid the need for biopsies is well noted by full-service law firm CMS. Its equIP program supports many start-ups incorporating AI into products and development processes.
Forum officially unveiled on 19 February to represent growing band of organizations designated against the UKCA mark.